关于HE4在卵巢癌瘤发生中的作用的最新见解
Emanuela Anastasi1, Antonella Farina1, Teresa Granato2
1Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
International journal of molecular sciences
|July 14, 2023
概括
人类卵巢膜蛋白4 (HE4) 显示出作为卵巢癌 (OC) 诊断,预后和复发的生物标志物具有前途. 本综述探讨了HE4在OC瘤发生中的作用,有助于向治疗的开发.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 卵巢癌 (OC) 经常出现晚期诊断和不良预后,推动生物标志物研究.
- 血清人体皮膜蛋白4 (HE4) 是早期OC检测,预后和复发监测的关键生物标志物.
研究的目的:
- 阐明HE4在卵巢癌瘤发生中的多方面的作用.
- 探索HE4在OC增殖,血管新生,转移和免疫反应中的参与.
- 评估HE4在指导卵巢癌向治疗策略方面的潜力.
主要方法:
- 文献综述侧重于HE4在卵巢癌中的致癌功能.
- 对HE4临床预测能力的现有证据的分析.
- 探索HE4在癌症进展中的分子机制.
主要成果:
- HE4与卵巢癌的诊断,预后和复发有关.
- 有证据表明HE4影响OC增殖,血管新生和免疫规避.
- 了解HE4的致癌功能对于治疗开发至关重要.
结论:
- HE4是一种重要的生物标志物,具有超出诊断的潜力,影响预后和治疗.
- 对HE4的瘤遗传作用的进一步研究可以改善卵巢癌的治疗.
- HE4可能成为新型卵巢癌治疗的关键标.
关键词:
HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4 HE4瘤发生的发生因子.卵巢癌是发生在卵巢的癌症.针对性治疗的目标治疗.更多相关视频
相关概念视频
Hormonal Control of the Ovarian Cycle
585
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
585
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Oogenesis
63.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


